Fuad Issa
Research Subjects
Fuad Issa has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Adam Edward Lang
James E Van Zandt VA Medical Center, Department of Pharmacy, Altoona, Pennsylvania, United States
1 shared publication Alik S. Widge
Massachusetts General Hospital, 149 13th Street; Charlestown, MA, 02129, USA
1 shared publicationAmy J. Osik
National Capital Region Pain Initiative & Tele-Pain Program, Walter Reed National Mili-tary Medical Center, Bethesda, Maryland
1 shared publicationAndre Machado
Cleveland Clinic Neurological Institute, 9500 Euclid Ave., Cleveland, OH, 44195, USA
1 shared publicationAndrew Buelt
C.W. Bill Young Veterans Administration Medical Center, Bay Pines, Florida (A.B.)
1 shared publication- Asiya K. Kazi
Defense Health Agency (DHA)
1 shared publication
Latest Publications
- 3 April 2024
- Published by Taylor & Francis in Psychosis
- Vol. 17 (2) , 201-212
A rapid review of literature on first episode psychosis among United States military service members
- 3 April 2024
- Published by Taylor & Francis in Psychosis
- Vol. 17 (2) , 201-212
A rapid review of literature on first episode psychosis among United States military service members
- Open Access
- 1 October 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (10) , 1440-1451
The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
The U.S. Department of Veterans Affairs and the U.S. Department of Defense partnered to update a previous guideline on managing depression that was published in 2016. This manuscript summarizes key... Description: In February 2022, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of major depre...
- 1 October 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (10) , 1440-1451
Open AccessThe Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
The U.S. Department of Veterans Affairs and the U.S. Department of Defense partnered to update a previous guideline on managing depression that was published in 2016. This manuscript summarizes key... Description: In February 2022, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of major depre...
- 1 August 2021
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 17 (7) , 87-100
Geographic analysis of military health system (MHS) buprenorphine prescribers and patients
Objective: To demonstrate the prevalence of opioid use disorder (OUD) in the military health system (MHS), geographically map OUD patients and providers, and offer policy recommendations to help increase buprenorphine waiver prescribing. Design: This study was a retrospective review of data from the MHS records. Deidentified records of MHS OUD patients receiving buprenorphine were utilized. Secondary data with nonpersonally identifiable information (PII) were used for pulling records of buprenorphine prescribing providers within the direct care system (MHS providers) and providers from the purchased care system (civilian facilities accepting TRICARE beneficiaries). Setting: This study reviewed records of individuals within the MHS, in the United States, and its territories. Patients and participants: Patients within the MHS system with a diagnosis of OUD. Providers, within the MHS or purchased care, who had prescribed buprenorphine were selected. Main outcome measured: The number of OUD patients in the MHS and providers caring for these OUD patients. In addition, geographical maps illustrating the dispersion of OUD patients, and prescribers were created. Results: The vast majority of MHS OUD patients receive their care from purchase care. Between 2015 and 2018, there has been a shift in the number OUD diagnosed patients by region, and the number of OUD prescribers. Conclusion: The MHS population, particularly active duty, is a transient population. As such, it is not a surprise that the population of OUD patients or prescribers varied by region during that time period. Furthermore, results demonstrate that there is a need to increase the number of buprenorphine-waivered prescribers within the MHS. Changes in policy may encourage more providers to obtain the waiver or increase patient load.
- 1 August 2021
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 17 (7) , 87-100
Geographic analysis of military health system (MHS) buprenorphine prescribers and patients
Objective: To demonstrate the prevalence of opioid use disorder (OUD) in the military health system (MHS), geographically map OUD patients and providers, and offer policy recommendations to help increase buprenorphine waiver prescribing. Design: This study was a retrospective review of data from the MHS records. Deidentified records of MHS OUD patients receiving buprenorphine were utilized. Secondary data with nonpersonally identifiable information (PII) were used for pulling records of buprenorphine prescribing providers within the direct care system (MHS providers) and providers from the purchased care system (civilian facilities accepting TRICARE beneficiaries). Setting: This study reviewed records of individuals within the MHS, in the United States, and its territories. Patients and participants: Patients within the MHS system with a diagnosis of OUD. Providers, within the MHS or purchased care, who had prescribed buprenorphine were selected. Main outcome measured: The number of OUD patients in the MHS and providers caring for these OUD patients. In addition, geographical maps illustrating the dispersion of OUD patients, and prescribers were created. Results: The vast majority of MHS OUD patients receive their care from purchase care. Between 2015 and 2018, there has been a shift in the number OUD diagnosed patients by region, and the number of OUD prescribers. Conclusion: The MHS population, particularly active duty, is a transient population. As such, it is not a surprise that the population of OUD patients or prescribers varied by region during that time period. Furthermore, results demonstrate that there is a need to increase the number of buprenorphine-waivered prescribers within the MHS. Changes in policy may encourage more providers to obtain the waiver or increase patient load.
- Open Access
- 1 June 2021
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 22, 100785
Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
- 1 June 2021
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 22, 100785
Open AccessDouble blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
- 1 June 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 138, 598-606
Advances in repetitive transcranial magnetic stimulation for posttraumatic stress disorder: A systematic review
- 1 June 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 138, 598-606
Advances in repetitive transcranial magnetic stimulation for posttraumatic stress disorder: A systematic review